Predicted to enable nucleotide binding activity and oxidoreductase activity. Predicted to be involved in extracellular matrix organization. Predicted to be active in extracellular matrix. Orthologous to human GFOD2 (glucose-fructose oxidoreductase domain containing 2). [provided by Alliance of Genome Resources, Apr 2022]